ClinicalTrials.gg
Status unknownNCT03327337AABTFTPFUpdated Aug 7, 2019

Arthroscopic Assisted Balloon Tibioplasty for the Treatment of Schatzker II-IV Tibial Plateau Fractures

An interventional study of Arthroscopic Assisted Balloon Tibioplasty in Arthroscopy, Tibial Fractures and Orthopedic, sponsored by Second Affiliated Hospital of Wenzhou Medical University. Status unknown. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-07.

Sponsored by Second Affiliated Hospital of Wenzhou Medical University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2019), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The investigators use existing resources to carry out this new technology, in accord with the standard of the patients, were randomized to traditional fracture balloon tibia fixation or arthroscopic reduction under angioplasty, the original data and data acquisition in a certain period of time corresponding to the patient, through statistical and epidemiological analysis and comparison of the method of professional data analysis discussion and experience according to the analysis results, the balloon angioplasty tibial arthroscopy and traditional open reduction and internal fixation for the clinical differences between postoperative recovery of tibial plateau articular surface reduction and joint function, and feedback the results to guide the clinical diagnosis and treatment.

Read the detailed description

The Balloon Tibioplasty arthroscopic assisted forming technique based on the existing data, the subject of the design, 1. patients met the inclusion criteria, were randomized to traditional fracture tibial fixation or balloon assisted arthroscopic reduction under angioplasty, through follow-up, statistical evaluation after operation were compared between the two techniques for clinical curative effect the difference of tibial plateau articular surface reduction and recovery of joint function. 2., through the clinical practice, operation and experience summary, found that the new technology in the operation of the existing deficiencies, in order to improve the technology. 3 guide clinical diagnosis and treatment through results feedback and analysis.The investigators use existing resources to carry out this new technology, in accord with the standard of the patients, were randomized to traditional fracture balloon tibia fixation or arthroscopic reduction under angioplasty, the original data and data acquisition in a certain period of time corresponding to the patient, through statistical and epidemiological analysis and comparison of the method of professional data analysis discussion and experience according to the analysis results, the balloon angioplasty tibial arthroscopy and traditional open reduction and internal fixation for the clinical differences between postoperative recovery of tibial plateau articular surface reduction and joint function, and feedback the results to guide the clinical diagnosis and treatment.

02

Conditions studied

  • Arthroscopy
  • Tibial Fractures
  • Orthopedic
  • Fracture Fixation

Browse trials for

03

In context

Tibial Fractures

135 studies on the registry are indexed under Tibial Fractures; 37 are open to participants now.

This study's planned enrollment of 40 is below the median of 65 across 91 interventional studies indexed under Tibial Fractures.

Browse Tibial Fractures studies →

Lead sponsor

Second Affiliated Hospital of Wenzhou Medical University is the lead sponsor of 137 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • fresh closed fracture X-ray and CT examination confirmed Schatzker II-IV type tibial plateau fracture patients.
  • the patient signed the .

Exclusion criteria

Exclusion Criteria:

  • Pathologic fractures, patients with neurologic disorders, and skeletally immature patients.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    experimental group

    operate with Arthroscopic Assisted Balloon Tibioplasty on this group patients

    Procedure: Arthroscopic Assisted Balloon Tibioplasty

  • Other
    control group

    operate with open reduction and internal fixation on this group patients

    Procedure: Arthroscopic Assisted Balloon Tibioplasty

Interventions

  • ProcedureArthroscopic Assisted Balloon Tibioplasty

    Under arthroscopy, the balloon supports the articular surface, with additional bone graft and necessary internal fixation

06

What researchers measure

Primary outcomes

  1. Rasmussen scores change after surgery

    the knee joint Rasmussen scores change after surgery

    Time frame: 3、6、12 and 24 mouth Rasmussen scores change after surgery

  2. Rasmunssen radiological evaluation scores change after surgery

    Rasmunssen radiological evaluation scores change after surgery

    Time frame: immediately, and at 2 weeks and 1, 3, 6, 12, and 24 months Rasmunssen radiological evaluation scores change after surgery

  3. The quality of reduction

    The quality of reduction will be determined based on postoperative CT scans, which can directly measure the amount of residual depression

    Time frame: 2 weeks and 1, 3, 6, 12, and 24 months postoperatively.

Secondary outcomes

  1. Intraoperative blood loss

    blood loss in surgery

    Time frame: Operation day

  2. Surgical duration

    Surgical duration

    Time frame: The day of the operation

  3. VAS pain scores change after surgery

    The severity of lower limb pain after surgery

    Time frame: from the day of the operation to the day of discharge from hospital (up to 2 weeks).

  4. Hospitalization period after surgery

    Hospitalization period after surgery

    Time frame: The day of the operation to the day of discharge

  5. Complications

    Complications including wound infection, reoperations, and posttraumatic arthritis (PTA) will be recorded.

    Time frame: 1, 3, 6, 12, and 24 months follow-up time. (PTA may not be seen in patients within the 24-month follow-up period, and we will perform follow-up for at least 10 years in all patients.)

  6. the Short-Form Health Survey (SF-36) questionnaire

    Health-related quality of life will be measured using the Short-Form Health Survey (SF-36) questionnaire during follow-up.

    Time frame: 1, 3, 6, 12, and 24 months follow-up time

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Wang JQ, Jiang BJ, Guo WJ, Zhang WJ, Li AB, Zhao YM. Arthroscopic-assisted balloon tibioplasty versus open reduction internal fixation (ORIF) for treatment of Schatzker II-IV tibial plateau fractures: study protocol of a randomised controlled trial. BMJ Open. 2018 Aug 8;8(8):e021667. doi: 10.1136/bmjopen-2018-021667. PubMed 30093519 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2020; primary completion for Dec 2022, 35 months later.

Of 39 interventional studies with no phase under Tibial Fractures, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 80. This study's planned 35 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2017
First posted
Oct 31, 2017
StartEst.
Jan 1, 2020
Primary completionEst.
Dec 31, 2022
CompletionEst.
Dec 31, 2022
Last update
Aug 7, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03327337
Responsible party
Sponsor
First posted
Oct 31, 2017
Start date
Jan 1, 2020 (estimated)
Primary completion
Dec 31, 2022 (estimated)
Completion
Dec 31, 2022 (estimated)
Last update
Aug 7, 2019

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion